Positions

Overview

  • Dr. Kulkarni received her initial medical training and internship at Bangalore Medical College and Research Institute with graduate studies completed at Harvard T.H. Chan School of Public Health. She completed a residency in Internal Medicine at Wayne State University. After completing her residency, Dr. Kulkarni began a clinical and research fellowship at UAB in 2013. Following this fellowship, she joined the UAB faculty in June 2016 as Instructor of Medicine.
  • Research Overview

  • Dr. Kulkarni's research interests include Interstitial Lung Disease and Pulmonary Fibrosis.
  • Principal Investigator On

    Investigator On

  • Private Grant  awarded by GENKYOTEX SA 2020 - 2025
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2018 - 2024
  • Private Grant  awarded by FIBROGEN, INC. 2020 - 2023
  • Private Grant  awarded by PRIME EDUCATION LLC 2020 - 2023
  • Private Grant  awarded by GALAPAGOS NV. 2020 - 2023
  • Private Grant  awarded by RESPIVANT SCIENCES, GMBH 2019 - 2022
  • Private Grant  awarded by ATYR PHARMA, INC. 2020 - 2022
  • Private Grant  awarded by MALLINCKRODT ARD, INC 2018 - 2021
  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease  awarded by Brigham and Women's Hospital 2018 - 2021
  • Pulmonary Fibrosis Foundation Biomarker and/or Patient Registry Protocols  awarded by University of Michigan 2018 - 2020
  • Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF_Pro) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype Prospective Outcomes (ILD-PRO) Registry  awarded by Duke University 2019 - 2020
  • Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)  awarded by University of Pittsburgh 2017 - 2020
  • Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary Fibrosis – CleanUP-IPF  awarded by University of Pittsburgh 2018 - 2020
  • Study of Co-trimoxazole and Proton Pump Inhibition Using Pragmatic Design in Idiopathic Pulmonary FibrosiCleanUP-IPF  awarded by Weill (Joan and Sanford I.) Medical College of Cornell University 2018 - 2019
  • Private Grant  awarded by CELGENE CORPORATION 2018 - 2019
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2017 - 2019
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2016 - 2019
  • Pulmonary Fibrosis Foundation Biomarker and/or Patient Registry Protocols  awarded by University of Michigan 2015 - 2018
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2017 - 2018
  • A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease  awarded by Brigham and Women's Hospital 2018
  • Private Grant  awarded by GLOBAL BLOOD THERAPEUTICS, INC. 2016 - 2018
  • Private Grant  awarded by GLOBAL BLOOD THERAPEUTICS, INC. 2016 - 2017
  • Full Name

  • Tejaswini Kulkarni